Key result
Local NO donor delivery prior to coronary stenting prevented acute and subacute stent thrombosis, resulting in 100% event-free survival at one month.
Why the study?
Does local NO donor delivery prevent acute and subacute stent thrombosis and bleeding complications in patients undergoing coronary stenting?
Observational (n=15)
No
Does local NO donor delivery prevent acute and subacute stent thrombosis and bleeding complications in patients undergoing coronary stenting?
Local NO donor delivery prior to stenting appears safe and may prevent acute and subacute stent thrombosis without the need for post-stenting heparin, though findings are limited by the lack of a control group.
Answers are grounded in this paper and cite their sources.
Should not yet change stenting practice; leaves open the role of local NO donors pending controlled trials.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Jeong et al. (1997) conducted an observational in Coronary artery disease (angina or myocardial infarction) requiring stenting (n=15). Local Nitric Oxide (NO) donor delivery (Molsidomine) was evaluated on Event-free survival at 1 month. Local NO donor delivery prior to coronary stenting prevented acute and subacute stent thrombosis, resulting in 100% event-free survival at one month.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: